Using gene expression profiling of breast cancer tissues, the present study confirms that MIAT expression level is significantly increased in breast cancer, specifically in the early stages of the disease (stage I and II), suggesting that MIAT overexpression is important in the early stages of breast oncogenesis and may play a key role throughout the development of malignancy. The gene discussed is MIAT; the disease is breast carcinoma.